SCHEMBL23892256

SCHEMBL23892256

C=CC1CCC(n2ccc3c(NC)ncnc32)C1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIP4K2A P48426 1/20 0.43
YTHDC1 Q96MU7 1/20 0.43
PRMT5 O14744 11/20 0.40
WDR77 Q9BQA1 9/20 0.40
NAE1 Q13564 2/20 0.33
CA2 P00918 2/20 0.33
GRK5 P34947 1/20 0.33
CSNK1A1 P48729 1/20 0.33
UBA6 A0AVT1 1/20 0.33
NEDD8 Q15843 1/20 0.33
UBA3 Q8TBC4 1/20 0.33
SAE1 Q9UBE0 1/20 0.33
UBA2 Q9UBT2 1/20 0.33
CCRL2 O00421 1/20 0.33
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21130086 0.84 PRMT5 (0.38) PIP4K2APRMT5WDR77
SCHEMBL25048531 0.83 YTHDC1 (0.47) PIP4K2AYTHDC1PRMT5WDR77NAE1
SCHEMBL10293822 0.83 PIP4K2A (0.49) PIP4K2AYTHDC1PRMT5WDR77NAE1
SCHEMBL18571704 0.81 MEN1 (0.41) PRMT5WDR77
SCHEMBL23892453 0.81 PIP4K2A (0.39) PIP4K2APRMT5WDR77UBA6
SCHEMBL18572230 0.81 PIP4K2A (0.39) PIP4K2APRMT5WDR77UBA6
SCHEMBL23892225 0.81 PIP4K2A (0.39) PIP4K2APRMT5WDR77UBA6
SCHEMBL25047950 0.78 PRMT5 (0.35) PIP4K2AYTHDC1PRMT5WDR77NAE1
SCHEMBL23892515 0.75 PRMT5 (0.44) PIP4K2AYTHDC1PRMT5WDR77ADORA3
SCHEMBL25047920 0.75 PIP4K2A (0.39) PIP4K2AYTHDC1PRMT5WDR77NAE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219496-A1 NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN Pharmaceutica NV (BE) 2023-08-02 EP disclosed
EP-3341368-B1 NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-10-06 EP disclosed